loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Mometasone Furoate

Menu
$ API Ref.Price (USD/KG) : 6,379Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14GLENMARK SPECLT

02 13INTERSECT ENT INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

MOMETASONE FUROATE

US Patent Number : 8109918

Drug Substance Claim :

Drug Product Claim :

Application Number : 209310

Patent Use Code : U-2272

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-03-12

blank

02

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

MOMETASONE FUROATE

US Patent Number : 7951131

Drug Substance Claim :

Drug Product Claim :

Application Number : 209310

Patent Use Code : U-2272

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-03-12

blank

03

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

MOMETASONE FUROATE

US Patent Number : 7951130

Drug Substance Claim :

Drug Product Claim :

Application Number : 209310

Patent Use Code : U-2272

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-03-12

blank

04

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

MOMETASONE FUROATE

US Patent Number : 8025635

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209310

Patent Use Code : U-2272

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-12

blank

05

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

MOMETASONE FUROATE

US Patent Number : 7713255

Drug Substance Claim :

Drug Product Claim :

Application Number : 209310

Patent Use Code : U-2272

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-03-12

blank

06

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

MOMETASONE FUROATE

US Patent Number : 10232152

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209310

Patent Use Code : U-2272

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-11-24

blank

07

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

MOMETASONE FUROATE

US Patent Number : 10357640

Drug Substance Claim :

Drug Product Claim :

Application Number : 209310

Patent Use Code : U-2272

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-10-03

blank

08

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

MOMETASONE FUROATE

US Patent Number : 7662141

Drug Substance Claim :

Drug Product Claim :

Application Number : 209310

Patent Use Code : U-2272

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-03-12

blank

09

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

MOMETASONE FUROATE

US Patent Number : 9585681

Drug Substance Claim :

Drug Product Claim :

Application Number : 209310

Patent Use Code : U-2272

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-04-04

blank

10

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

MOMETASONE FUROATE

US Patent Number : 7544192

Drug Substance Claim :

Drug Product Claim :

Application Number : 209310

Patent Use Code : U-2272

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-29

blank